By slicing and dicing a dataset from 277 million patients at 1,591 hospitals, Epic publishes findings more quickly than traditional, peer-reviewed journals.
(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or ...
Introduction A robust and systematic approach is key to ensuring that people living with heart failure with preserved ejection fraction (HFpEF) receive a timely and accurate diagnosis and ...